Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

Host Determinants of Expression of the Helicobacter pylori BabA Adhesin.

Kable ME, Hansen LM, Styer CM, Deck SL, Rakhimova O, Shevtsova A, Eaton KA, Martin ME, Gideonsson P, Borén T, Solnick JV.

Sci Rep. 2017 Apr 18;7:46499. doi: 10.1038/srep46499.

2.

Fallacy of the Unique Genome: Sequence Diversity within Single Helicobacter pylori Strains.

Draper JL, Hansen LM, Bernick DL, Abedrabbo S, Underwood JG, Kong N, Huang BC, Weis AM, Weimer BC, van Vliet AH, Pourmand N, Solnick JV, Karplus K, Ottemann KM.

MBio. 2017 Feb 21;8(1). pii: e02321-16. doi: 10.1128/mBio.02321-16.

3.

Structural Insights into Polymorphic ABO Glycan Binding by Helicobacter pylori.

Moonens K, Gideonsson P, Subedi S, Bugaytsova J, Romaõ E, Mendez M, Nordén J, Fallah M, Rakhimova L, Shevtsova A, Lahmann M, Castaldo G, Brännström K, Coppens F, Lo AW, Ny T, Solnick JV, Vandenbussche G, Oscarson S, Hammarström L, Arnqvist A, Berg DE, Muyldermans S, Borén T, Remaut H.

Cell Host Microbe. 2016 Jan 13;19(1):55-66. doi: 10.1016/j.chom.2015.12.004.

4.

Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.

Polage CR, Gyorke CE, Kennedy MA, Leslie JL, Chin DL, Wang S, Nguyen HH, Huang B, Tang YW, Lee LW, Kim K, Taylor S, Romano PS, Panacek EA, Goodell PB, Solnick JV, Cohen SH.

JAMA Intern Med. 2015 Nov;175(11):1792-801. doi: 10.1001/jamainternmed.2015.4114.

5.

The Serum Immunoglobulin G Glycosylation Signature of Gastric Cancer.

Ruhaak LR, Barkauskas DA, Torres J, Cooke CL, Wu LD, Stroble C, Ozcan S, Williams CC, Camorlinga M, Rocke DM, Lebrilla CB, Solnick JV.

EuPA Open Proteom. 2015 Mar 1;6:1-9.

6.

Evidence of convergent evolution in humans and macaques supports an adaptive role for copy number variation of the β-defensin-2 gene.

Ottolini B, Hornsby MJ, Abujaber R, MacArthur JA, Badge RM, Schwarzacher T, Albertson DG, Bevins CL, Solnick JV, Hollox EJ.

Genome Biol Evol. 2014 Oct 27;6(11):3025-38. doi: 10.1093/gbe/evu236.

7.

The gastric microbial community, Helicobacter pylori colonization, and disease.

Martin ME, Solnick JV.

Gut Microbes. 2014 May-Jun;5(3):345-50. doi: 10.4161/gmic.28573. Epub 2014 Mar 18.

8.

Serum glycan signatures of gastric cancer.

Ozcan S, Barkauskas DA, Renee Ruhaak L, Torres J, Cooke CL, An HJ, Hua S, Williams CC, Dimapasoc LM, Han Kim J, Camorlinga-Ponce M, Rocke D, Lebrilla CB, Solnick JV.

Cancer Prev Res (Phila). 2014 Feb;7(2):226-35. doi: 10.1158/1940-6207.CAPR-13-0235. Epub 2013 Dec 10.

9.

Environmental determinants of transformation efficiency in Helicobacter pylori.

Moore ME, Lam A, Bhatnagar S, Solnick JV.

J Bacteriol. 2014 Jan;196(2):337-44. doi: 10.1128/JB.00633-13. Epub 2013 Nov 1.

10.

The impact of Helicobacter pylori infection on the gastric microbiota of the rhesus macaque.

Martin ME, Bhatnagar S, George MD, Paster BJ, Canfield DR, Eisen JA, Solnick JV.

PLoS One. 2013 Oct 8;8(10):e76375. doi: 10.1371/journal.pone.0076375. eCollection 2013.

11.

Biomarkers of Helicobacter pylori-associated gastric cancer.

Cooke CL, Torres J, Solnick JV.

Gut Microbes. 2013 Nov-Dec;4(6):532-40. doi: 10.4161/gmic.25720. Epub 2013 Jul 12. Review.

12.

Functional plasticity in the type IV secretion system of Helicobacter pylori.

Barrozo RM, Cooke CL, Hansen LM, Lam AM, Gaddy JA, Johnson EM, Cariaga TA, Suarez G, Peek RM Jr, Cover TL, Solnick JV.

PLoS Pathog. 2013 Feb;9(2):e1003189. doi: 10.1371/journal.ppat.1003189. Epub 2013 Feb 28.

13.

Predicting the outcome of infectious diseases: variability among inbred mice as a new and powerful tool for biomarker discovery.

Martin ME, Dieter JA, Luo Z, Baumgarth N, Solnick JV.

MBio. 2012 Oct 16;3(5):e00199-12. doi: 10.1128/mBio.00199-12.

14.

Evaluation of Clostridium difficile fecal load and limit of detection during a prospective comparison of two molecular tests, the illumigene C. difficile and Xpert C. difficile/Epi tests.

Gyorke CE, Wang S, Leslie JL, Cohen SH, Solnick JV, Polage CR.

J Clin Microbiol. 2013 Jan;51(1):278-80. doi: 10.1128/JCM.02120-12. Epub 2012 Oct 10.

15.

Outcomes in patients tested for Clostridium difficile toxins.

Polage CR, Chin DL, Leslie JL, Tang J, Cohen SH, Solnick JV.

Diagn Microbiol Infect Dis. 2012 Dec;74(4):369-73. doi: 10.1016/j.diagmicrobio.2012.08.019. Epub 2012 Sep 23.

16.

Conserved transcriptional unit organization of the cag pathogenicity island among Helicobacter pylori strains.

Ta LH, Hansen LM, Sause WE, Shiva O, Millstein A, Ottemann KM, Castillo AR, Solnick JV.

Front Cell Infect Microbiol. 2012 Apr 20;2:46. doi: 10.3389/fcimb.2012.00046. eCollection 2012.

17.

Role of fecal Clostridium difficile load in discrepancies between toxin tests and PCR: is quantitation the next step in C. difficile testing?

Leslie JL, Cohen SH, Solnick JV, Polage CR.

Eur J Clin Microbiol Infect Dis. 2012 Dec;31(12):3295-9. doi: 10.1007/s10096-012-1695-6. Epub 2012 Jul 20. Erratum in: Eur J Clin Microbiol Infect Dis. 2012 Dec;31(12):3301.

18.

Nosocomial diarrhea: evaluation and treatment of causes other than Clostridium difficile.

Polage CR, Solnick JV, Cohen SH.

Clin Infect Dis. 2012 Oct;55(7):982-9. doi: 10.1093/cid/cis551. Epub 2012 Jun 14. Review.

19.

In vivo expression of Helicobacter pylori virulence genes in patients with gastritis, ulcer, and gastric cancer.

Avilés-Jiménez F, Reyes-Leon A, Nieto-Patlán E, Hansen LM, Burgueño J, Ramos IP, Camorlinga-Ponce M, Bermúdez H, Blancas JM, Cabrera L, Ribas-Aparicio RM, Solnick JV, Torres-López J.

Infect Immun. 2012 Feb;80(2):594-601. doi: 10.1128/IAI.05845-11. Epub 2011 Nov 28.

20.

Use of real-time, label-free analysis in revealing low-affinity binding to blood group antigens by Helicobacter pylori.

Fei YY, Schmidt A, Bylund G, Johansson DX, Henriksson S, Lebrilla C, Solnick JV, Borén T, Zhu XD.

Anal Chem. 2011 Aug 15;83(16):6336-41. doi: 10.1021/ac201260c. Epub 2011 Jul 19.

Supplemental Content

Loading ...
Support Center